Feature Channels: Transplantation

Filters close
Newswise: Experts in Transplantation, Engineered Cells and Pediatrics Join Growing Roswell Park Cell Therapy Program
Released: 4-Dec-2023 3:50 PM EST
Experts in Transplantation, Engineered Cells and Pediatrics Join Growing Roswell Park Cell Therapy Program
Roswell Park Comprehensive Cancer Center

Three physician-scientists who have relocated to Buffalo, New York, to join Roswell Park Comprehensive Cancer Center will apply highly specialized transplantation and cell therapy (TCT) expertise to both patient care and the development of New York State’s first cell therapy manufacturing and research hub. Brian Betts, MD, has joined Roswell Park as Vice Chair of Strategic Initiatives within the Transplant & Cellular Therapy Section, Department of Medicine; Kanwaldeep Mallhi, MD, was named Associate Professor of Oncology and Clinical Director of Pediatric Transplantation and Cellular Therapy in the Department of Pediatrics; and Shernan Holtan, MD, will join the Roswell Park faculty in February as Chief of Blood and Marrow Transplant in the Department of Medicine.

Newswise: Triple Transplant Recipient Reflects on Living, Love and Gratitude
Released: 4-Dec-2023 11:05 AM EST
Triple Transplant Recipient Reflects on Living, Love and Gratitude
Cedars-Sinai

This holiday season, Valance Sams, Sr. hopes to finish the most important thank-you note he’s ever written—one he’s been pondering for months. It’s been challenging to get all that he wants to say down on paper, in just the right way. Most days, a flood of emotions gets in his way.

Newswise: Desai Sethi Urology Institute Performs First Prepubertal Male Fertility Preservation
Released: 30-Nov-2023 1:05 PM EST
Desai Sethi Urology Institute Performs First Prepubertal Male Fertility Preservation
University of Miami Health System, Miller School of Medicine

The investigational procedure, done in collaboration with University of Pittsburgh Medical Center (UPMC), harvests testicular tissue containing stem cells in prepubertal boys who are about to undergo treatments for cancer or other conditions that might result in infertility.

Newswise: Long-standing hormone treatment for donated hearts found to be ineffective
28-Nov-2023 2:05 PM EST
Long-standing hormone treatment for donated hearts found to be ineffective
Washington University in St. Louis

A study from Washington University School of Medicine in St. Louis and Mid-America Transplant showed that the long-standing practice of treating deceased organ donors with thyroid hormone does not help preserve heart function, may cause harm and should be discontinued.

Newswise: Memorial Sloan Kettering Cancer Center and NMDP/Be The Match Launch “American Symphony: Become a Lifesaver” Campaign
28-Nov-2023 4:05 PM EST
Memorial Sloan Kettering Cancer Center and NMDP/Be The Match Launch “American Symphony: Become a Lifesaver” Campaign
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) and NMDP/Be The Match® today announced the launch of the “American Symphony: Become a Lifesaver” campaign to increase registration of blood stem cell and marrow donors to the national registry and improve access to blood stem cell transplants.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: Hackensack Meridian Children’s Health Medical Director of Pediatric Kidney Transplant Appointed as Co-Chair of National Kidney Transplant Working Group
Released: 16-Nov-2023 3:05 PM EST
Hackensack Meridian Children’s Health Medical Director of Pediatric Kidney Transplant Appointed as Co-Chair of National Kidney Transplant Working Group
Hackensack Meridian Health

Namrata G. Jain, MD, medical director of Pediatric Kidney Transplant at Joseph M. Sanzari Children’s Hospital at Hackensack University Medical Center, and associate professor of Pediatrics at Hackensack Meridian School of Medicine, has been appointed co-chair of the Transplant Working Group of the prestigious Pediatric Nephrology Research Consortium (PNRC).

Released: 16-Nov-2023 11:05 AM EST
Four ways organ transplants are being transformed to save more lives
Mayo Clinic

Despite a record year for organ donation last year in the U.S., an estimated 17 people die every day waiting for a transplant. Yet Mayo Clinic transplant experts are optimistic that solutions to some of the biggest transplant challenges are on the horizon, thanks to new technology, research and innovations.

Released: 7-Nov-2023 1:05 PM EST
MSU working to help promote success of Type 1 diabetes treatments with support from JDRF
Michigan State University

JDRF, the world’s largest nonprofit supporter of Type 1 diabetes research, has awarded a $750,000 grant to a team of Michigan State University researchers.

Released: 6-Nov-2023 10:05 AM EST
Brain implant may enable communication from thoughts alone
Duke University

Prosthetic decodes signals from brain’s speech center to predict what sound someone is trying to say.

Released: 3-Nov-2023 10:05 AM EDT
Study reveals untapped potential to increase eye donations needed for sight-restoring surgeries
University of Southampton

Patients in end-of-life care settings are rarely asked about eye donation despite positive views towards it. Healthcare professionals need training to discuss eye donation with patients.

Released: 23-Oct-2023 1:05 PM EDT
Children’s Hospital Los Angeles Researchers Develop Clinical Tool to Predict if a Child in Acute Liver Failure Will Need a Transplant
Children's Hospital Los Angeles

Children's Hospital Los Angeles has developed a novel decision tool for pediatric acute liver failure that predicts the urgency of transplant need.

Released: 20-Oct-2023 5:00 PM EDT
Potato starch supplements could be solution to bone marrow transplant complications
Michigan Medicine - University of Michigan

Research shows it could potentially prevent Graft versus Host Disease from occurring.

Released: 19-Oct-2023 1:05 PM EDT
Eye implant may be used to treat diabetes
Kungliga Tekniska Högskolan (KTH) [Royal Institute of Technology]

Researchers in Sweden have developed a microscale device for implantation in the eye, which presents new opportunities for cell-based treatment of diabetes and other diseases

Newswise: Beth Israel Lahey Health Launches Heart Transplant Program
Released: 5-Oct-2023 9:05 AM EDT
Beth Israel Lahey Health Launches Heart Transplant Program
Beth Israel Lahey Health

Beth Israel Lahey Health has expanded its cardiovascular services to include heart transplantation based at Beth Israel Deaconess Medical Center.

Released: 2-Oct-2023 9:55 AM EDT
Researchers develop mixture of compounds to help preserve organs before transplantation
Federation of American Societies for Experimental Biology (FASEB)

Using zebrafish as a model, investigators have determined a suitable combination of chemical compounds in which to store hearts, and potentially other organs, when frozen for extended periods of time before transplantation.

   
Newswise: September Research Highlights
Released: 29-Sep-2023 12:05 PM EDT
September Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for September 2023.

26-Sep-2023 3:35 PM EDT
Cleveland Clinic Researchers Develop New Model for Prioritizing Lung Transplant Candidates
Cleveland Clinic

CLEVELAND: A team from Cleveland Clinic has developed a new model for prioritizing patients waiting for a lung transplant, aimed at improving outcomes and reducing deaths among those in need of donor lungs. The new method offers an improved strategy for organ allocation by taking into account how the time a patient has spent on the waiting list could impact the severity of their disease and the urgency of their need for a transplant. The results of a study looking at this new method were published today in The American Journal of Respiratory and Critical Care Medicine.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Released: 27-Sep-2023 9:50 AM EDT
CHOP Researchers Improve Fitness of Cells Used in Cell Transplants
Children's Hospital of Philadelphia

A readily available, inexpensive small molecule drug can improve the fitness of hematopoietic stem and progenitor cells (HSPCs) that are modified outside of the body, potentially improving the success of procedures like ex vivo gene therapy, according to a new study by researchers at Children’s Hospital of Philadelphia (CHOP).

Released: 6-Sep-2023 10:55 AM EDT
T-Cells Infiltrate Brain, Cause Respiratory Distress in Condition Affecting the Immunocompromised
College of Veterinary Medicine, University of Illinois Urbana-Champaign

When an immunocompromised person’s system begins to recover and produce more white blood cells, it’s usually a good thing – unless they develop a potentially deadly inflammatory condition.

Newswise: Heart transplant patients from socioeconomically distressed communities face higher mortality, organ failure risk
Released: 31-Aug-2023 7:05 PM EDT
Heart transplant patients from socioeconomically distressed communities face higher mortality, organ failure risk
University of California, Los Angeles (UCLA), Health Sciences

FINDINGS People from socioeconomically distressed communities who underwent heart transplantation between 2004 and 2018 faced a 10% greater relative risk of experiencing graft failure and dying within five years compared to people from non-distressed communities. In addition, following implementation of the 2018 UNOS Heart Allocation policy, transplant recipients between 2018 and 2022 faced an approximately 20% increase in relative risk of dying or experiencing graft failure within three years compared with the pre-policy period.

Released: 30-Aug-2023 12:00 PM EDT
MD Anderson Research Highlights for August 30, 2023
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments include a novel computational tool to detect single base pair DNA changes in single-cell sequencing data, a potential target to treat hypertension caused by drugs commonly used in organ transplants, further insights into the steps involved in genetic recombination, a novel treatment target for a subset of adenoid cystic carcinoma (ACC), a combination therapy that improves outcomes in certain patients with acute myeloid leukemia (AML), and a target for treating prolonged cytopenia in patients with relapsed/refractory large B cell lymphoma treated with chimeric antigen receptor (CAR) T cell therapy.

   
Newswise: Multi-Center Study Finds Routine Genetic Testing Could Benefit Patients with Advanced Inherited Heart Muscle Disease
Released: 30-Aug-2023 8:00 AM EDT
Multi-Center Study Finds Routine Genetic Testing Could Benefit Patients with Advanced Inherited Heart Muscle Disease
MedStar Washington Hospital Center

A multi-site, five-year study led by a MedStar Heart & Vascular Institute cardiologist and fellow researchers from across the country have demonstrated the benefits of routine genetic testing for patients with advanced disease from dilated cardiomyopathy (DCM), a disease of the heart muscle and their at-risk family members.

Released: 22-Aug-2023 10:05 AM EDT
Paired liver exchange developed by Boston College economists results in first four-way liver exchange
Boston College

In a breakthrough in liver transplantation that may lead to the ability to connect more living donors and patients, a new matching system designed by a team led by Boston College economists enabled the world’s first four-way liver exchange and a cascade of additional matches.

Newswise: Cell Therapy That Repairs Cornea Damage with Patient’s Own Stem Cells Achieves Positive Phase I Trial Results
Released: 18-Aug-2023 2:10 PM EDT
Cell Therapy That Repairs Cornea Damage with Patient’s Own Stem Cells Achieves Positive Phase I Trial Results
Massachusetts Eye and Ear

Cultivated autologous limbal epithelial cells (CALEC) transplant, in which stem cells from the healthy eye and transplanted into the injured eye, for significant cornea injuries was found safe and led to gains in preliminary phase I clinical trial.

Newswise: Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
Released: 18-Aug-2023 12:05 PM EDT
Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
Johns Hopkins Medicine

A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.

Released: 10-Aug-2023 12:05 PM EDT
Apply Today! Advance Media Registration for American College of Surgeons Clinical Congress
American College of Surgeons (ACS)

Members of the media can apply today to cover the American College of Surgeons Clinical Congress 2023.

Newswise: New Chief of Pediatric Bone Marrow Transplantation and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Released: 9-Aug-2023 10:15 AM EDT
New Chief of Pediatric Bone Marrow Transplantation and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Niketa C. Shah, MD, as chief of Pediatric Bone Marrow Transplantation and Cellular Therapies at New Jersey’s leading cancer program.

Released: 2-Aug-2023 6:00 PM EDT
Bridge to Life Divests Certain Assets to TransMedics
Bridge to Life Ltd.

Bridge to Life Ltd. (BTL), a leading global supplier of organ preservation and perfusion technologies, announced today its divestiture of certain assets to TransMedics, Inc., a wholly owned subsidiary of TransMedics Group, Inc. (NASDAQ: TMDX), including its EVOSS heart and lung and LifeCradle heart perfusion assets.

Newswise: Researchers discover a novel pathway that minimizes liver injury during transplantation
1-Aug-2023 4:05 PM EDT
Researchers discover a novel pathway that minimizes liver injury during transplantation
University of California, Los Angeles (UCLA), Health Sciences

New research shows how using molecular tools and alternative gene splicing can make a protein called CEACAM1 more protective against liver injury during transplantation, thus reducing organ injury and ultimately improving post-transplant outcomes.

Released: 1-Aug-2023 5:05 PM EDT
Tip Sheet: Talking about pain with your doctor, the microbiome and graft-vs.-host disease, and RNA’s role in prostate cancer
Fred Hutchinson Cancer Center

Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news. Reporting on wildfire smoke? Fred Hutch clinicians and researchers are available to their expertise. Dr. Trang VoPham is an epidemiologist focusing on environmental exposures and risk, follow her on social media.

Released: 28-Jul-2023 8:05 AM EDT
American Society of Nephrology Applauds Senate Passage of the Securing the U.S. Organ Procurement and Transplantation Act (S. 1668)
American Society of Nephrology (ASN)

The United States Senate unanimously passed the Securing the U.S. Organ Procurement Transplantation Network (OPTN) Act (S. 1668), following House passage earlier this week, marking a new era for the United States transplant system.

Released: 27-Jul-2023 12:50 PM EDT
Study Shows Mitochondrial Transplantation Effective in Reversing Damage to Kidneys and Kidney Cells
Wake Forest University School of Medicine

According to the National Kidney Foundation, more than 100,000 Americans are waiting for a kidney transplant, and the demand for donated kidneys far exceeds the supply. In fact, only 25,498 kidney transplants were performed in 2022, and kidney disease impacts 37 million people in the U.S. But a new preclinical study, led by scientists at Wake Forest University School of Medicine, shows that a new technology called mitochondrial transplantation holds promise as a potential therapy that could change the kidney transplant landscape.

Released: 26-Jul-2023 12:00 PM EDT
American Society of Nephrology Celebrates House Passage of the Securing the U.S. Organ Procurement Transplantation Network (OPTN) Act (H.R. 2544)
American Society of Nephrology (ASN)

The American Society of Nephrology (ASN) celebrates the unanimous passage of the Securing the U.S. Organ Procurement Transplantation Network (OPTN) Act (H.R. 2544) by the United States House of Representatives. This bipartisan legislation will increase transparency, accountability, and competition in the U.S. transplant system.

Newswise:Video Embedded cedars-sinai-patient-receives-rare-triple-organ-transplant
VIDEO
Released: 24-Jul-2023 2:45 PM EDT
Cedars-Sinai Patient Receives Rare Triple Organ Transplant
Cedars-Sinai

Valance Sams Sr.’s world was turned upside down 10 years ago when he was diagnosed with sarcoidosis, a rare inflammatory disease that caused a buildup of scar tissue on his heart and left him unable to work, exercise or even walk.

Newswise: Study Shows Positive Outcomes for First Three U.S. Living HIV-To-HIV Kidney Transplant Donors
Released: 24-Jul-2023 12:55 PM EDT
Study Shows Positive Outcomes for First Three U.S. Living HIV-To-HIV Kidney Transplant Donors
Johns Hopkins Medicine

Based on findings from a study published today in the journal, The Lancet Regional Health – Americas, researchers at Johns Hopkins Medicine and three collaborating medical institutions suggest that people living with the human immunodeficiency virus (HIV) who donate a kidney to other people living with HIV (PLWH) have a low risk of developing end-stage kidney disease (ESKD) or other kidney problems in the years following the donation.

17-Jul-2023 7:05 PM EDT
Study sheds light on cellular interactions that lead to liver transplant survival
University of California, Los Angeles (UCLA), Health Sciences

A new study, which involved experiments on mice and human patients, uncovered an important communication pathway between two molecules called CEACAM1 (CC1) and TIM-3, finding that the pathway plays a crucial role in controlling the body's immune response during liver transplantation.

Released: 19-Jul-2023 1:10 PM EDT
Dr. Anthony Atala and WFIRM Team Awarded $1 Million KidneyX Track 2 Prize for Revolutionary 3D Vascularized Biomimetic Renal Construct Platform
Wake Forest Institute for Regenerative Medicine

In the next step toward producing the answer to kidney transplantation shortages, Dr. Anthony Atala, Director of the Wake Forest Institute for Regenerative Medicine (WFIRM), and the kidney research team, have been awarded the prestigious KidneyX Track 2 $1 Million Prize for work based on a 3D kidney construct platform.

   
Released: 19-Jul-2023 8:50 AM EDT
American Society of Nephrology Urges Congress to Increase Transparency, Accountability, and Competition in Transplant Care
American Society of Nephrology (ASN)

Approximately 90,000 Americans, including 1,100 children are currently waiting for a kidney transplant. Tragically, 12 Americans will die today waiting for a kidney. Advocates from the American Society of Nephrology (ASN) are on Capitol Hill today urging Congress to implement reforms that will help maximize access to transplant care for the 37 million Americans living with kidney diseases; the 8th leading cause of death in the United States.

Newswise: Georgia Hospital Improves Organ Donation Process
Released: 18-Jul-2023 3:05 PM EDT
Georgia Hospital Improves Organ Donation Process
American Association of Critical-Care Nurses (AACN)

An initiative at Northeast Georgia Medical Center’s hospital campus in Gainesville created a hospital culture that values organ donation as a standard of care for patients and families, leading to a sustained increase in referrals, donors and transplanted organs.

Newswise: First Robotic Liver Transplant in U.S. Performed by Washington University Surgeons
Released: 17-Jul-2023 3:20 PM EDT
First Robotic Liver Transplant in U.S. Performed by Washington University Surgeons
Washington University in St. Louis

A surgical team from Washington University School of Medicine in St. Louis recently performed the first robotic liver transplant in the U.S. in May at Barnes-Jewish Hospital.

Newswise: Ochsner Participates in New Study Showing Potential Benefits of Normothermic Machine Perfusion in Liver Transplantation
Released: 17-Jul-2023 2:10 PM EDT
Ochsner Participates in New Study Showing Potential Benefits of Normothermic Machine Perfusion in Liver Transplantation
Ochsner Health

The randomized controlled study was conducted by 15 liver transplant centers in the United States, including Ochsner Health Liver Transplant Institute, and compared the use of normothermic machine preservation (NMP)—which maintains the organ at normal body temperature-- with static cold storage (SCS) in 383 donor organs.

Newswise: Cedars-Sinai Hits New High for Organ Transplants
Released: 17-Jul-2023 11:55 AM EDT
Cedars-Sinai Hits New High for Organ Transplants
Cedars-Sinai

Fiscal year 2023, which ended June 30, proved to be the busiest year yet for Cedars-Sinai’s Comprehensive Transplant Center and Smidt Heart Institute, with more than 600 organs transplanted.

Newswise: In historic procedure, donor liver protects heart transplant
Released: 13-Jul-2023 11:50 AM EDT
In historic procedure, donor liver protects heart transplant
UW Medicine

Doctors in Seattle are reporting a history-making case in which a patient received two donor organs, a liver and a heart, to prevent the extreme likelihood that her body would reject a donor heart transplanted alone. In this innovative case, the organ recipient’s own healthy liver was transplanted, domino-like, into a second patient who had advanced liver disease.

Newswise: Lessons Learned from World’s First Successful Transplant of Genetically-Modified Pig Heart into Human Patient
29-Jun-2023 2:30 PM EDT
Lessons Learned from World’s First Successful Transplant of Genetically-Modified Pig Heart into Human Patient
University of Maryland School of Medicine

A new study published today in The Lancet has revealed the most extensive analysis to date on what led to the eventual heart failure in the world's first successful transplant of a genetically-modified pig heart into a human patient.

Released: 28-Jun-2023 3:05 PM EDT
Icahn School of Medicine at Mount Sinai Researchers Awarded $15.1 Million Grant to Explore Immune Rejection of Transplanted Organs
Mount Sinai Health System

Striving to improve organ transplant survival rates, internationally renowned researchers in immunology and bioengineering at the Icahn School of Medicine at Mount Sinai have received $15.1 million from the National Institute of Allergy and Infectious Diseases (NIAID) to lead a novel, five-year multi-center research program that will explore trained immunity—the innate immune system’s ability to remember infections and other insults—as a target for preventing organ transplant rejection.

27-Jun-2023 8:00 AM EDT
Antibody Treatment Prevents Graft Versus Host Disease, a Major Bone Marrow Transplant Complication, in Advanced Preclinical Tests
Perelman School of Medicine at the University of Pennsylvania

An experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease (GVHD) in the intestines, without causing broad immune suppression, in a preclinical study led by researchers from Penn Medicine and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and published today in Science Translational Medicine.



close
1.22555